Who Owns Achieve Life Sciences Stock?
NASDAQ: ACHVHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 82.10%
- Held by insiders
- 0.91%
- Institutional holders
- 153
- Institutions 82.1%
- Insiders 0.9%
- Public and other 17.0%
Who owns Achieve Life Sciences stock?
Institutional investors own about 82.1% of Achieve Life Sciences's shares, spread across 153 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.91% of ACHV.
The largest institutional holders are Frazier Life Sciences Management, L.P. (7.40%), TPG GP A, LLC (6.68%) and venBio Partners LLC (5.75%). Together, the top 10 institutions control 51.4% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their ACHV positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ACHV
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7.61M | 7.40% | +100.0% |
| TPG GP A, LLC | 6.88M | 6.68% | +100.0% |
| venBio Partners LLC | 5.91M | 5.75% | +100.0% |
| Logos Global Management LP | 5.42M | 5.27% | +100.0% |
| Blackrock Inc. | 5.27M | 5.12% | +1099.9% |
| Franklin Resources, Inc. | 4.95M | 4.81% | +13.4% |
| Paradigm Biocapital Advisors LP | 4.95M | 4.81% | +100.0% |
| Vanguard Capital Management LLC | 4.14M | 4.02% | +87.8% |
| Propel Bio Management, LLC | 4.03M | 3.92% | +6.5% |
| Marshall Wace LLP | 3.77M | 3.66% | +269.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ACHV
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.11M | 3.02% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 2.22M | 2.16% |
| iShares Trust-iShares Russell 2000 ETF | 1.96M | 1.91% |
| Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF | 1.43M | 1.39% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.42M | 1.38% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 1.10M | 1.06% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 957.39K | 0.93% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 851.83K | 0.83% |
| iShares Trust-iShares Russell 2000 Growth ETF | 736.62K | 0.72% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 412.54K | 0.40% |
Frequently asked questions
Who is the largest shareholder of Achieve Life Sciences?
Frazier Life Sciences Management, L.P. is the largest institutional shareholder of ACHV, owning 7.40% of shares outstanding (7.61M shares) as of its latest 13F filing.
What percentage of Achieve Life Sciences is owned by institutions?
Institutions own about 82.1% of ACHV shares and 82.8% of the public float.
How much of Achieve Life Sciences do insiders own?
Insiders, such as officers and directors, own about 0.91% of ACHV shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.